Correction [0.03%]
改正错误
[This corrects the article DOI: 10.1080/26895269.2025.2522257.]. © 2025 Taylor & Francis Group, LLC.
Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy [0.03%]
接受睾丸激素性别确认激素治疗的变性人出现持续月经出血
Sav Zwickl,Alex Fang Qi Wong,Laura Burchill et al.
Sav Zwickl et al.
Background: The cessation of menstruation is a common and desired outcome of testosterone gender-affirming hormone therapy (GAHT), for trans and gender diverse (collectively referred to as trans) individuals recorded fema...
Prostatic diseases in transgender women: A systematic review of diagnosis, risk, and management [0.03%]
性别重置女性的前列腺疾病：诊断、风险和治疗的系统评价
Alice Bourillon,Cyrille Guillot-Tantay,Lucas Freton et al.
Alice Bourillon et al.
Introduction: Most transgender women have their prostate left in situ throughout and after their transition. Managing prostate‑related conditions in transgender women remains challenging due to the lack of clear recommen...
Which transgender and gender diverse groups benefit most from E-health? Subgroup analyses of the randomized controlled trial i2TransHealth in Germany [0.03%]
哪些变性人和性别多样化群体最受益于电子健康？德国i2TransHealth随机对照试验的亚组分析
Janis Renner,Peer Briken,Arne Dekker et al.
Janis Renner et al.
Background: Transgender and gender diverse (TGD) people, particularly those living in underserved remote areas, often face barriers to accessing primary and specialty healthcare services due to geographic isolation and th...
Gender recognition and health rights vis-à-vis reproductive justice: Exploring the experiences of transmasculine persons in India [0.03%]
性别认同与健康权利视阈下的生殖正义：探索印度男变性人的经历
Chanchal De Boxi,Seema Singh,Debdas Roy
Chanchal De Boxi
Background: The narratives of trans women dominate the discourse on 'trans rights' in India, thereby marginalizing transmasculine identities that continue to be 'invisible' in public perception. Trans men are often neglec...
Exploring alcohol use and harm reduction techniques among transgender and gender diverse youth in Canada: A qualitative study [0.03%]
加拿大 transgender 和性别多样青年中的饮酒行为及减害技术定性研究
Theodore F Quinn,Alexandra Uhrig,Sarah S Dermody et al.
Theodore F Quinn et al.
Background: Compared to their cisgender peers, transgender and gender-diverse (TGD) youth and young adults report problematic drinking patterns (e.g. frequency of use, greater likelihood of use, and elevated risks for harmful use), as well ...
Worldwide prevalence of anxiety in transgender persons: Systematic review with meta-analysis [0.03%]
关于跨性别者焦虑症流行率的全球系统评价和荟萃分析
Davi Oliveira Teles,Raquel Alves de Oliveira,Manuela de Mendonça Figueirêdo Coelho et al.
Davi Oliveira Teles et al.
Objective: This systematic review and meta-analysis estimate the global pooled prevalence of anxiety among transgender individuals. Methods: ...
"Fuel for the fire": Trans rage as a motivating force against cisgenderism [0.03%]
“火上浇油：“跨性别怒火作为反对顺性本质的动因
Salem Skelton
Salem Skelton
Background: Trans rage is a sense of rage toward cisgenderism that is commonly, but not exclusively, experienced by trans peoples, individually and collectively. Despite its revolutionary history, trans rage and the ways ...
Structural barriers to accessing gender-affirming care for transgender and gender diverse (TGD) individuals in the United States [0.03%]
美国变性人和性别多样人群体获取性别确认医疗的结构性障碍
Ellesse-Roselee L Akré,Harry Barbee,Nik M Lampe
Ellesse-Roselee L Akré
Background: Access to gender-affirming care (GAC) is important for the health of transgender and gender-diverse (TGD) populations, but many encounter significant barriers. This study examines the experiences of TGD individuals in accessing ...
QT interval changes in transgender/gender diverse adolescents receiving gonadotropin-releasing hormone agonist and gender-affirming hormonal treatment [0.03%]
性别不安青少年在使用促性腺激素释放激素激动剂和性别肯定荷尔蒙治疗下的QT间期变化
Hussein Zaitoon,Livia Kapusta,Galit Israeli et al.
Hussein Zaitoon et al.
Background : Hormones play a significant role in modulating cardiac electrophysiology. Gonadotropin-releasing hormone agonists (GnRHa) and gender-affirming hormonal treatment (GAHT) may impact QTc intervals, which could have clinical implic...